Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report report published on Sunday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Performance

AEMD opened at $0.65 on Friday. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.10. The company has a market capitalization of $9.14 million, a P/E ratio of -0.23 and a beta of 1.61. The stock has a fifty day moving average of $0.53 and a 200-day moving average of $0.44.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.